• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Acthar Ambassador Program???





There is nothing to hide. This is an industry standard practice. All managed by an outside vendor who also does most of the other companies patient ambassador programs.